APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Daptomycin API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Daptomycin API Industry Growth and Trends Forecast to 2032

Report ID 17398256012 January 202690 pages

Choose your research edition.

Industry ResearchDaptomycin API Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Daptomycin API Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Daptomycin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Daptomycin API Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Daptomycin API Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Daptomycin API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Daptomycin API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Daptomycin API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Daptomycin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Daptomycin API include Chongqing DaXin Pharmaceutical Co, Suzhou Pharmaceutical Technology Co, Livzon Group Fuzhou Fuxing Pharmaceutical Co, Huazhong Pharmaceutical Co, Xellia Pharmaceuticals, Tecoland Corporation, Rochem International Inc and Athos, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Daptomycin API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Daptomycin API market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Daptomycin API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Daptomycin API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Daptomycin API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Daptomycin API Market by Company

Chongqing DaXin Pharmaceutical Co

Suzhou Pharmaceutical Technology Co

Livzon Group Fuzhou Fuxing Pharmaceutical Co

Huazhong Pharmaceutical Co

Xellia Pharmaceuticals

Tecoland Corporation

Rochem International Inc

Athos

Daptomycin API Segment by Type

0.99

0.98

Others

Daptomycin API Segment by Application

350mg/vial

500mg/vial

Others

Daptomycin API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Daptomycin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Daptomycin API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Daptomycin API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Daptomycin API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Daptomycin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.99 Table 2. Major Company of 0.98 Table 3. Major Company of Others Table 4. Global Daptomycin API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Daptomycin API Sales by Type (2021-2026) & (Tons) Table 6. Global Daptomycin API Sales Market Share in Volume by Type (2021-2026) Table 7. Global Daptomycin API Sales by Type (2021-2026) & (US$ Million) Table 8. Global Daptomycin API Sales Market Share in Value by Type (2021-2026) Table 9. Global Daptomycin API Price by Type (2021-2026) & (US$/Ton) Table 10. Global Daptomycin API Sales by Type (2027-2032) & (Tons) Table 11. Global Daptomycin API Sales Market Share in Volume by Type (2027-2032) Table 12. Global Daptomycin API Sales by Type (2027-2032) & (US$ Million) Table 13. Global Daptomycin API Sales Market Share in Value by Type (2027-2032) Table 14. Global Daptomycin API Price by Type (2027-2032) & (US$/Ton) Table 15. North America Daptomycin API Sales by Type (2021-2026) & (Tons) Table 16. North America Daptomycin API Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Daptomycin API Sales by Type (2021-2026) & (Tons) Table 18. Europe Daptomycin API Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Daptomycin API Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific Daptomycin API Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Daptomycin API Sales by Type (2021-2026) & (Tons) Table 22. Latin America Daptomycin API Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Daptomycin API Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa Daptomycin API Sales by Type (2021-2026) & (US$ Million) Table 25. Daptomycin API Industry Trends Table 26. Daptomycin API Industry Drivers Table 27. Daptomycin API Industry Opportunities and Challenges Table 28. Daptomycin API Industry Restraints Table 29. Global Daptomycin API Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Daptomycin API Revenue Market Share by Company (2021-2026) Table 31. Global Daptomycin API Sales by Company (2021-2026) & (Tons) Table 32. Global Daptomycin API Sales Share by Company (2021-2026) Table 33. Global Daptomycin API Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global Daptomycin API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Daptomycin API Major Company Production Sites and Headquarters Table 36. Global Daptomycin API Company, Product Type & Application Table 37. Global Daptomycin API Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Daptomycin API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Daptomycin API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Daptomycin API Sales by Region (2021-2026) & (Tons) Table 42. Global Daptomycin API Sales Market Share in Volume by Region (2021-2026) Table 43. Global Daptomycin API Sales by Region (2021-2026) & (US$ Million) Table 44. Global Daptomycin API Sales Market Share in Value by Region (2021-2026) Table 45. Global Daptomycin API Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global Daptomycin API Sales by Region (2027-2032) & (Tons) Table 47. Global Daptomycin API Sales Market Share in Volume by Region (2027-2032) Table 48. Global Daptomycin API Sales by Region (2027-2032) & (US$ Million) Table 49. Global Daptomycin API Sales Market Share in Value by Region (2027-2032) Table 50. Global Daptomycin API Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global Daptomycin API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Daptomycin API Sales by Application (2021-2026) & (Tons) Table 53. Global Daptomycin API Sales Market Share in Volume by Application (2021-2026) Table 54. Global Daptomycin API Sales by Application (2021-2026) & (US$ Million) Table 55. Global Daptomycin API Sales Market Share in Value by Application (2021-2026) Table 56. Global Daptomycin API Price by Application (2021-2026) & (US$/Ton) Table 57. Global Daptomycin API Sales by Application (2027-2032) & (Tons) Table 58. Global Daptomycin API Sales Market Share in Volume by Application (2027-2032) Table 59. Global Daptomycin API Sales by Application (2027-2032) & (US$ Million) Table 60. Global Daptomycin API Sales Market Share in Value by Application (2027-2032) Table 61. Global Daptomycin API Price by Application (2027-2032) & (US$/Ton) Table 62. North America Daptomycin API Sales by Application (2021-2026) & (Tons) Table 63. North America Daptomycin API Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Daptomycin API Sales by Application (2021-2026) & (Tons) Table 65. Europe Daptomycin API Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Daptomycin API Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific Daptomycin API Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Daptomycin API Sales by Application (2021-2026) & (Tons) Table 69. Latin America Daptomycin API Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Daptomycin API Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa Daptomycin API Sales by Application (2021-2026) & (US$ Million) Table 72. Chongqing DaXin Pharmaceutical Co Company Information Table 73. Chongqing DaXin Pharmaceutical Co Business Overview Table 74. Chongqing DaXin Pharmaceutical Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Chongqing DaXin Pharmaceutical Co Daptomycin API Product Portfolio Table 76. Chongqing DaXin Pharmaceutical Co Recent Development Table 77. Suzhou Pharmaceutical Technology Co Company Information Table 78. Suzhou Pharmaceutical Technology Co Business Overview Table 79. Suzhou Pharmaceutical Technology Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Suzhou Pharmaceutical Technology Co Daptomycin API Product Portfolio Table 81. Suzhou Pharmaceutical Technology Co Recent Development Table 82. Livzon Group Fuzhou Fuxing Pharmaceutical Co Company Information Table 83. Livzon Group Fuzhou Fuxing Pharmaceutical Co Business Overview Table 84. Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Product Portfolio Table 86. Livzon Group Fuzhou Fuxing Pharmaceutical Co Recent Development Table 87. Huazhong Pharmaceutical Co Company Information Table 88. Huazhong Pharmaceutical Co Business Overview Table 89. Huazhong Pharmaceutical Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Huazhong Pharmaceutical Co Daptomycin API Product Portfolio Table 91. Huazhong Pharmaceutical Co Recent Development Table 92. Xellia Pharmaceuticals Company Information Table 93. Xellia Pharmaceuticals Business Overview Table 94. Xellia Pharmaceuticals Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Xellia Pharmaceuticals Daptomycin API Product Portfolio Table 96. Xellia Pharmaceuticals Recent Development Table 97. Tecoland Corporation Company Information Table 98. Tecoland Corporation Business Overview Table 99. Tecoland Corporation Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Tecoland Corporation Daptomycin API Product Portfolio Table 101. Tecoland Corporation Recent Development Table 102. Rochem International Inc Company Information Table 103. Rochem International Inc Business Overview Table 104. Rochem International Inc Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Rochem International Inc Daptomycin API Product Portfolio Table 106. Rochem International Inc Recent Development Table 107. Athos Company Information Table 108. Athos Business Overview Table 109. Athos Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Athos Daptomycin API Product Portfolio Table 111. Athos Recent Development Table 112. North America Daptomycin API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 113. North America Daptomycin API Sales by Country (2021-2026) & (Tons) Table 114. North America Daptomycin API Sales Market Share by Country (2021-2026) Table 115. North America Daptomycin API Sales Forecast by Country (2027-2032) & (Tons) Table 116. North America Daptomycin API Sales Market Share Forecast by Country (2027-2032) Table 117. North America Daptomycin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Daptomycin API Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Daptomycin API Market Share by Country (2021-2026) Table 120. North America Daptomycin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Daptomycin API Market Share Forecast by Country (2027-2032) Table 122. Europe Daptomycin API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 123. Europe Daptomycin API Sales by Country (2021-2026) & (Tons) Table 124. Europe Daptomycin API Sales Market Share by Country (2021-2026) Table 125. Europe Daptomycin API Sales Forecast by Country (2027-2032) & (Tons) Table 126. Europe Daptomycin API Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Daptomycin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Daptomycin API Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Daptomycin API Market Share by Country (2021-2026) Table 130. Europe Daptomycin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Daptomycin API Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Daptomycin API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Daptomycin API Sales by Country (2021-2026) & (Tons) Table 134. Asia-Pacific Daptomycin API Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Daptomycin API Sales Forecast by Country (2027-2032) & (Tons) Table 136. Asia-Pacific Daptomycin API Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Daptomycin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Daptomycin API Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Daptomycin API Market Share by Country (2021-2026) Table 140. Asia-Pacific Daptomycin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Daptomycin API Market Share Forecast by Country (2027-2032) Table 142. Latin America Daptomycin API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 143. Latin America Daptomycin API Sales by Country (2021-2026) & (Tons) Table 144. Latin America Daptomycin API Sales Market Share by Country (2021-2026) Table 145. Latin America Daptomycin API Sales Forecast by Country (2027-2032) & (Tons) Table 146. Latin America Daptomycin API Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Daptomycin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Daptomycin API Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Daptomycin API Market Share by Country (2021-2026) Table 150. Latin America Daptomycin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Daptomycin API Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Daptomycin API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Daptomycin API Sales by Country (2021-2026) & (Tons) Table 154. Middle East and Africa Daptomycin API Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Daptomycin API Sales Forecast by Country (2027-2032) & (Tons) Table 156. Middle East and Africa Daptomycin API Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Daptomycin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Daptomycin API Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Daptomycin API Market Share by Country (2021-2026) Table 160. Middle East and Africa Daptomycin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Daptomycin API Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Daptomycin API Distributors List Table 165. Daptomycin API Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Daptomycin API Image Figure 2. Global Daptomycin API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Daptomycin API Market Size (2021-2032) & (US$ Million) Figure 4. Global Daptomycin API Sales (2021-2032) & (Tons) Figure 5. 0.99 Image Figure 6. Global 0.99 Sales YoY Growth (2021-2032) & (Tons) Figure 7. 0.98 Image Figure 8. Global 0.98 Sales YoY Growth (2021-2032) & (Tons) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global Daptomycin API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Daptomycin API Market Share by Type 2025 VS 2032 Figure 13. North America Daptomycin API Sales Market Share in Volume by Type in 2025 Figure 14. North America Daptomycin API Sales Market Share in Value by Type in 2025 Figure 15. Europe Daptomycin API Sales Market Share in Volume by Type in 2025 Figure 16. Europe Daptomycin API Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Daptomycin API Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Daptomycin API Sales Market Share in Value by Type in 2025 Figure 19. Latin America Daptomycin API Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Daptomycin API Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Daptomycin API Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Daptomycin API Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Daptomycin API Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. 350mg/vial Image Figure 26. Global 350mg/vial Sales YoY Growth (2021-2032) & (Tons) Figure 27. 500mg/vial Image Figure 28. Global 500mg/vial Sales YoY Growth (2021-2032) & (Tons) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Daptomycin API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Daptomycin API Market Share by Application 2025 VS 2032 Figure 33. North America Daptomycin API Sales Market Share in Volume by Application in 2025 Figure 34. North America Daptomycin API Sales Market Share in Value by Application in 2025 Figure 35. Europe Daptomycin API Sales Market Share in Volume by Application in 2025 Figure 36. Europe Daptomycin API Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Daptomycin API Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Daptomycin API Sales Market Share in Value by Application in 2025 Figure 39. Latin America Daptomycin API Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Daptomycin API Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Daptomycin API Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Daptomycin API Sales Market Share in Value by Application in 2025 Figure 43. North America Daptomycin API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Daptomycin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Daptomycin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Daptomycin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Daptomycin API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Daptomycin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Daptomycin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Daptomycin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Daptomycin API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Daptomycin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Daptomycin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Daptomycin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Daptomycin API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Daptomycin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Daptomycin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Daptomycin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Daptomycin API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Daptomycin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Daptomycin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Daptomycin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Daptomycin API Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Daptomycin API Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 0.99
  • 0.98
  • Others
Applications
  • 350mg/vial
  • 500mg/vial
  • Others
Companies covered
  • Chongqing DaXin Pharmaceutical Co
  • Suzhou Pharmaceutical Technology Co
  • Livzon Group Fuzhou Fuxing Pharmaceutical Co
  • Huazhong Pharmaceutical Co
  • Xellia Pharmaceuticals
  • Tecoland Corporation
  • Rochem International Inc
  • Athos

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Daptomycin API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Daptomycin API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Daptomycin API Market by Type
  6. 1.3.1 0.99
  7. 1.3.2 0.98
  8. 1.3.3 Others
  9. 1.4 Global Daptomycin API Market Size by Type
  10. 1.4.1 Global Daptomycin API Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Daptomycin API Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Daptomycin API Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Daptomycin API Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Daptomycin API Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Daptomycin API Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Daptomycin API Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Daptomycin API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Daptomycin API Industry Trends
  2. 2.2 Daptomycin API Industry Drivers
  3. 2.3 Daptomycin API Industry Opportunities and Challenges
  4. 2.4 Daptomycin API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Daptomycin API Revenue (2021-2026)
  2. 3.2 Global Top Players by Daptomycin API Sales (2021-2026)
  3. 3.3 Global Top Players by Daptomycin API Price (2021-2026)
  4. 3.4 Global Daptomycin API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Daptomycin API Major Company Production Sites & Headquarters
  6. 3.6 Global Daptomycin API Company, Product Type & Application
  7. 3.7 Global Daptomycin API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Daptomycin API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Daptomycin API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Daptomycin API Tier 1, Tier 2, and Tier 3
4 Daptomycin API Regional Status and Outlook
  1. 4.1 Global Daptomycin API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Daptomycin API Historic Market Size by Region
  3. 4.2.1 Global Daptomycin API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Daptomycin API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Daptomycin API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Daptomycin API Forecasted Market Size by Region
  7. 4.3.1 Global Daptomycin API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Daptomycin API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Daptomycin API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Daptomycin API by Application
  1. 5.1 Daptomycin API Market by Application
  2. 5.1.1 350mg/vial
  3. 5.1.2 500mg/vial
  4. 5.1.3 Others
  5. 5.2 Global Daptomycin API Market Size by Application
  6. 5.2.1 Global Daptomycin API Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Daptomycin API Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Daptomycin API Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Daptomycin API Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Daptomycin API Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Daptomycin API Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Daptomycin API Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Daptomycin API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing DaXin Pharmaceutical Co
  2. 6.1.1 Chongqing DaXin Pharmaceutical Co Company Information
  3. 6.1.2 Chongqing DaXin Pharmaceutical Co Business Overview
  4. 6.1.3 Chongqing DaXin Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing DaXin Pharmaceutical Co Daptomycin API Product Portfolio
  6. 6.1.5 Chongqing DaXin Pharmaceutical Co Recent Developments
  7. 6.2 Suzhou Pharmaceutical Technology Co
  8. 6.2.1 Suzhou Pharmaceutical Technology Co Company Information
  9. 6.2.2 Suzhou Pharmaceutical Technology Co Business Overview
  10. 6.2.3 Suzhou Pharmaceutical Technology Co Daptomycin API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Suzhou Pharmaceutical Technology Co Daptomycin API Product Portfolio
  12. 6.2.5 Suzhou Pharmaceutical Technology Co Recent Developments
  13. 6.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co
  14. 6.3.1 Livzon Group Fuzhou Fuxing Pharmaceutical Co Company Information
  15. 6.3.2 Livzon Group Fuzhou Fuxing Pharmaceutical Co Business Overview
  16. 6.3.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Product Portfolio
  18. 6.3.5 Livzon Group Fuzhou Fuxing Pharmaceutical Co Recent Developments
  19. 6.4 Huazhong Pharmaceutical Co
  20. 6.4.1 Huazhong Pharmaceutical Co Company Information
  21. 6.4.2 Huazhong Pharmaceutical Co Business Overview
  22. 6.4.3 Huazhong Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Huazhong Pharmaceutical Co Daptomycin API Product Portfolio
  24. 6.4.5 Huazhong Pharmaceutical Co Recent Developments
  25. 6.5 Xellia Pharmaceuticals
  26. 6.5.1 Xellia Pharmaceuticals Company Information
  27. 6.5.2 Xellia Pharmaceuticals Business Overview
  28. 6.5.3 Xellia Pharmaceuticals Daptomycin API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Xellia Pharmaceuticals Daptomycin API Product Portfolio
  30. 6.5.5 Xellia Pharmaceuticals Recent Developments
  31. 6.6 Tecoland Corporation
  32. 6.6.1 Tecoland Corporation Company Information
  33. 6.6.2 Tecoland Corporation Business Overview
  34. 6.6.3 Tecoland Corporation Daptomycin API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Tecoland Corporation Daptomycin API Product Portfolio
  36. 6.6.5 Tecoland Corporation Recent Developments
  37. 6.7 Rochem International Inc
  38. 6.7.1 Rochem International Inc Company Information
  39. 6.7.2 Rochem International Inc Business Overview
  40. 6.7.3 Rochem International Inc Daptomycin API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Rochem International Inc Daptomycin API Product Portfolio
  42. 6.7.5 Rochem International Inc Recent Developments
  43. 6.8 Athos
  44. 6.8.1 Athos Company Information
  45. 6.8.2 Athos Business Overview
  46. 6.8.3 Athos Daptomycin API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Athos Daptomycin API Product Portfolio
  48. 6.8.5 Athos Recent Developments
7 North America by Country
  1. 7.1 North America Daptomycin API Sales by Country
  2. 7.1.1 North America Daptomycin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Daptomycin API Sales by Country (2021-2026)
  4. 7.1.3 North America Daptomycin API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Daptomycin API Market Size by Country
  6. 7.2.1 North America Daptomycin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Daptomycin API Market Size by Country (2021-2026)
  8. 7.2.3 North America Daptomycin API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Daptomycin API Sales by Country
  2. 8.1.1 Europe Daptomycin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Daptomycin API Sales by Country (2021-2026)
  4. 8.1.3 Europe Daptomycin API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Daptomycin API Market Size by Country
  6. 8.2.1 Europe Daptomycin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Daptomycin API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Daptomycin API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Daptomycin API Sales by Country
  2. 9.1.1 Asia-Pacific Daptomycin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Daptomycin API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Daptomycin API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Daptomycin API Market Size by Country
  6. 9.2.1 Asia-Pacific Daptomycin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Daptomycin API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Daptomycin API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Daptomycin API Sales by Country
  2. 10.1.1 South America Daptomycin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Daptomycin API Sales by Country (2021-2026)
  4. 10.1.3 South America Daptomycin API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Daptomycin API Market Size by Country
  6. 10.2.1 South America Daptomycin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Daptomycin API Market Size by Country (2021-2026)
  8. 10.2.3 South America Daptomycin API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Daptomycin API Sales by Country
  2. 11.1.1 Middle East and Africa Daptomycin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Daptomycin API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Daptomycin API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Daptomycin API Market Size by Country
  6. 11.2.1 Middle East and Africa Daptomycin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Daptomycin API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Daptomycin API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Daptomycin API Value Chain Analysis
  2. 12.1.1 Daptomycin API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Daptomycin API Production Mode & Process
  7. 12.2 Daptomycin API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Daptomycin API Distributors
  10. 12.2.3 Daptomycin API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst